Blood test predicts which kids with autism may benefit from bumetanide
NCT ID NCT07005414
First seen May 05, 2026 · Last updated May 19, 2026 · Updated 2 times
Summary
This study tested whether bumetanide, a drug, can reduce autism symptoms in children ages 3 to 6 who were identified as likely to respond well based on a blood test and computer model. 66 children were split into two groups: one received bumetanide plus behavioral therapy, the other only behavioral therapy. The goal was to see if bumetanide could improve social skills and overall symptoms over three months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200092, China
Conditions
Explore the condition pages connected to this study.